Successful treatment of status migrainosus after electroconvulsive therapy with dihydroergotamine

Headache

Volumn 45, Issue 4, 2005, Pages 378-380

  Stead, Matt ^a   Josephs, Keith A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Dihydroergotamine; Electroconvulsive therapy; Status migrainosus

Indexed keywords

AMITRIPTYLINE; DIHYDROERGOTAMINE; IBUPROFEN; KETOROLAC; NARATRIPTAN; SUMATRIPTAN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MAJOR DEPRESSION; MIGRAINE WITHOUT AURA; PAIN ASSESSMENT; PRIORITY JOURNAL; TREATMENT OUTCOME;

DIHYDROERGOTAMINE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MIDDLE AGED; MIGRAINE DISORDERS; VASOCONSTRICTOR AGENTS;

EID: 17244374090     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2005.05077_1.x     Document Type: Article

References (13)

1. Gomez J. Subjective side-effects of ECT. Br J Psychiatry. 1975;127:609-611.
2. Sackheim HA, Ross FR, Hopkins N, Calev L, Devanand DP. Subjective side effects acutely following ECT: associations with treatment modality and clinical response. Convuls Ther. 1987;3:100-110.
3. Headache Classification Committee. The international classification of headache disorders, 2nd ed. Cephalalgia, 2004;24:32-33.
4. Weinstein RM. Migraine occurring as sequela of electroconvulsive therapy. Headache. 1993;33:45.
5. Oms A, Miro E, Rojo J. Sumatriptan was effective in electroconvulsive therapy headache. Anesthesiology. 1998;89:1291-1292.
6. Hawken ER, Delva NJ, Lawson S. Successful use of propranolol in migraine associated with electroconvulsive therapy. Headache. 2001;41:92-96.
7. Markowitz JS, Kellner CH, DeVane CL, Beale MD, Folk J, Burns C, Liston HL. Intranasal sumatriptan in post-ECT headache: results of an open-label trial. J ECT. 2001;17:280-283.
8. Folkerts H. Migraine after electroconvulsive therapy. Convuls Ther. 1995;11:212-215.
9. Silberstein SD, McCrory DC. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Headache. 2003;43:144-166.
10. Diener HC, Peters C, Rudzio M. Ergotamine, flunarazine, and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraineurs. J Neurol. 1991;238:245-250.
11. Goadsby PJ, Edvinsson L. The trigeminovascular system in migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993;33:48-56.
12. Goadsby PJ, Gundlach AL. Localization of [3H]-dihydroergotamine binding sites in the cat central nervous system: relevance to migraine. Ann Neurol. 1993;33:48-56.
13. Hoskins KL, Kaube H, Goadsby PJ. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine: a c-Fos and electrophysiology study. Brain. 1996;119:249-256.